Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Atomwise Inc. is managing 2 pending office actions in the Semiconductors, Circuits & Optics technology area. These 2 actions are distributed across 2 distinct examiners and 2 distinct art units. SULTANA, DILARA is identified as the busiest examiner for the portfolio, with 1 pending office action currently under review.
With 2 pending office actions, 2 distinct examiners, and 2 distinct art units, the portfolio's current activity is entirely decentralized. Each pending matter is being reviewed by a different individual in a different specialized unit of the patent office. This structure ensures that the outcome of one 1 pending office action does not directly influence the other, providing the company with diversified risk.
The busiest examiner, SULTANA, DILARA, handles 1 of the 2 pending actions, reflecting an even distribution of the workload. For the practitioner, this requires managing 2 separate prosecution tracks with no overlap in examiner or art unit preferences. This decentralized approach in the Semiconductors, Circuits & Optics area suggests that the company's current filings cover distinct technical sub-specialties.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SULTANA, DILARA | 1 | 80.9% | +16.2% |
| MCMILLIAN, KARA RENITA | 1 | 30.9% | +37.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697356 | CHARACTERIZATION OF INTERACTIONS BETWEEN COMPOUNDS AND POLYMERS USING NEGATIVE POSE DATA AND MODEL CONDITIONING | SULTANA, DILARA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284416 | COMPOUND 7AI IN TREATING EWING SARCOMA BY INHIBITING OTUD7A | MCMILLIAN, KARA RENITA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697356 | CHARACTERIZATION OF INTERACTIONS BETWEEN COMPOUNDS AND POLYMERS USING NEGATIVE POSE DATA AND MODEL CONDITIONING | SULTANA, DILARA | — |
| 18284416 | COMPOUND 7AI IN TREATING EWING SARCOMA BY INHIBITING OTUD7A | MCMILLIAN, KARA RENITA | — |
| Art Unit | Apps |
|---|---|
| 2858 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18697356 | CHARACTERIZATION OF INTERACTIONS BETWEEN COMPOUNDS AND POLYMERS USING NEGATIVE POSE DATA AND MODEL CONDITIONING | SULTANA, DILARA | 2858 | §103 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18284416 | COMPOUND 7AI IN TREATING EWING SARCOMA BY INHIBITING OTUD7A | MCMILLIAN, KARA RENITA | 1623 | §102§112 | Non-Final OA | — | Pending | Sep 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAtomwise Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Dilara Sultana has the most, with 1 of Atomwise Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
